The new cancer-effective treatments developed on mice (prost....? and endostatin) are side-effect free, not subject to tumor resistance, and totally effective--a definite competitor for ONXX. The mfg'r stock went up $45 this AM, rumor that Squibb interested in purchase.Conceivebly the finest science this century and the most devastating news for ONXX
Agree Chart_ up.....technical analysis shows Onxx moving higher. As Buy_Onxx pointed out the trading range is getting very narrow but we keep making higher lows. This is very positive...Above $9 1/2 this stock can run to $11 easily (within 1-2 days).
I have a sneaky suspision that Onxx will move above $10 early next week...we might see a run in anticipation to ASCO (American Society of Clinical Oncology) to the $11-12 area.
Test of the highs $14-16 will depend on news coming out of ASCO. I am expecting good news coming from final results of Phase II trials from head and neck cancer. I think Lehman knows something with a target of $25....Also Montgomery and UBS, the underwriters, have a great record as discussed by ONXXTOOCHEAP.
I like this stock and would recommend buying agrresively (Of course I am holding 8,000 shares :-)). Do your research in Onxx I think you will be very impressed with this small bio-tech.